Expression of defective virus and cytokine genes in murine AIDS.
A syndrome characterized by severe immunodeficiency and lymphoproliferation develops in susceptible strains of mice infected with a mixture of murine leukemia viruses (MuLVs) designated LP-BM5 MuLV. The etiologic agent in this mixture has been shown to be a replication-defective virus (BM5d) with a 4.8-kb genome that required replication-competent helper viruses, primarily ecotropic (BM5e), for cell-to-cell spread in the host. In the present study, we studied the expression of BM5d and BM5e in tissues of infected mice at various times after inoculation in relation to the expression of cytokine genes that may contribute to the pathogenesis of this disorder. Northern (RNA) analysis of total RNA showed that BM5d was expressed at significant levels in lymphoid tissues within 1 week of infection and that the levels of expression increased with time after inoculation. By 16 weeks postinfection, BM5d was expressed in all tissues examined. Expression of BM5e was relatively more restricted to lymphoid tissues and was detected at lower levels than expression of BM5d at early times after infection, but this virus was expressed in all tissues by 16 weeks. Infection with the virus mixture was associated with constitutive expression of tumor necrosis factor in all tissues examined and of interleukin-1 (IL-1) in lymphoid tissues within 1 week of infection, and at later times with widespread expression of these cytokines and gamma interferon. Also, the levels of interferon regulatory factor 1 mRNA were significantly increased in all infected tissues during the infection. In contrast, expression of IL-3, IL-4, IL-5, and IL-6 was not detectable by Northern analysis of the respective mRNAs in any infected tissue at early or late times postinfection.
Cheung
S C
SC
Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.
Chattopadhyay
S K
SK
Morse
H C
HC
Pitha
P M
PM
D000818:Animals; D016207:Cytokines / Q000235:genetics*; D004268:DNA-Binding Proteins / Q000235:genetics; D003673:Defective Viruses / Q000235:genetics*; D015870:Gene Expression; D050856:Interferon Regulatory Factor-1; D007370:Interferon Type I / Q000235:genetics; D007371:Interferon-gamma / Q000235:genetics; D007378:Interleukins / Q000235:genetics; D009052:Leukemia Virus, Murine / Q000235:genetics*; D051379:Mice; D008810:Mice, Inbred C57BL; D008908:Mink Cell Focus-Inducing Viruses / Q000235:genetics*; D016183:Murine Acquired Immunodeficiency Syndrome / Q000235:genetics* / Q000382:microbiology; D009693:Nucleic Acid Hybridization; D010750:Phosphoproteins / Q000235:genetics; D012313:RNA / Q000235:genetics / Q000302:isolation & purification; D015347:RNA Probes; D014157:Transcription Factors / Q000235:genetics; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
D016207:Cytokines; D004268:DNA-Binding Proteins; D050856:Interferon Regulatory Factor-1; D007370:Interferon Type I; D007378:Interleukins; C494258:Irf1 protein, mouse; D010750:Phosphoproteins; D015347:RNA Probes; D014157:Transcription Factors; D014409:Tumor Necrosis Factor-alpha; D012313:RNA; D007371:Interferon-gamma